Clinical Trial

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-10-05; most recent amendment 2025-05-12.
Status change: Not Yet Recruiting → Enrolling by Invitation 2022-08-09
Trial Details
NCT Number NCT05082077
Lead Sponsor Paragonix Technologies
Conditions Liver Diseases, Liver Dysfunction, Liver Transplant Disorder, Liver Transplant Rejection
Enrollment 1,000 participants
Start Date 2022-03-15
Primary Completion 2027-08 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-15